Domestic pharmaceutical firms bent upon exploring overseas markets

Published: 2003-02-10 06:59:00

Updated: 2003-02-10 06:59:00

Pharmaceutical business sources say that the leading Korean pharmaceutical firms have been endeavoring to further explore overseas markets in a bid to avert the cut-throat competition in the domestic pharmaceutical market and expand their presence in the world market via establishment of subsidia...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK